These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29405696)

  • 1. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
    Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
    ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
    Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
    J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.
    Capul AA; de la Torre JC
    Virology; 2008 Dec; 382(1):107-14. PubMed ID: 18929379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse genetics approaches to combat pathogenic arenaviruses.
    de la Torre JC
    Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    de la Torre JC
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.
    Kim YJ; Cubitt B; Chen E; Hull MV; Chatterjee AK; Cai Y; Kuhn JH; de la Torre JC
    Antiviral Res; 2019 Sep; 169():104558. PubMed ID: 31302150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arenavirus extinction through lethal mutagenesis.
    de la Torre JC
    Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
    Ortiz-Riaño E; Ngo N; Devito S; Eggink D; Munger J; Shaw ML; de la Torre JC; Martínez-Sobrido L
    J Virol; 2014 Jan; 88(2):878-89. PubMed ID: 24198417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid.
    Vázquez-Calvo Á; Martín-Acebes MA; Sáiz JC; Ngo N; Sobrino F; de la Torre JC
    Antiviral Res; 2013 Aug; 99(2):172-9. PubMed ID: 23735299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.
    Iwasaki M; Ngo N; Cubitt B; Teijaro JR; de la Torre JC
    J Virol; 2015 Dec; 89(23):12166-77. PubMed ID: 26401045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
    Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease.
    Urata S; Yun N; Pasquato A; Paessler S; Kunz S; de la Torre JC
    J Virol; 2011 Jan; 85(2):795-803. PubMed ID: 21068251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium hydrogen exchangers contribute to arenavirus cell entry.
    Iwasaki M; Ngo N; de la Torre JC
    J Virol; 2014 Jan; 88(1):643-54. PubMed ID: 24173224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
    Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.
    Iwasaki M; Cubitt B; Sullivan BM; de la Torre JC
    J Virol; 2016 Jan; 90(6):3187-97. PubMed ID: 26739049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel antiviral strategies to combat human Arenavirus infections.
    Kunz S; de la Torre JC
    Curr Mol Med; 2005 Dec; 5(8):735-51. PubMed ID: 16375709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).
    Ruiz-Jarabo CM; Ly C; Domingo E; de la Torre JC
    Virology; 2003 Mar; 308(1):37-47. PubMed ID: 12706088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arenavirus Quasispecies and Their Biological Implications.
    Grande-Pérez A; Martin V; Moreno H; de la Torre JC
    Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.